Skip to main content

An official website of the United States government

You have 2 new alerts

Request For Information at the Frederick National Laboratory for Cancer Research for Front End and Analysis Tool Development and Production Data Processing Support for the NCI Genomic Data Commons

General Information

  • Contract Opportunity Type: Special Notice (Original)
  • Original Published Date: Mar 11, 2022 10:35 am EST
  • Original Response Date: Mar 31, 2022 05:00 pm EDT
  • Inactive Policy: 15 days after response date
  • Original Inactive Date:
  • Initiative:

Classification

  • Original Set Aside:
  • Product Service Code:
  • NAICS Code:
    • 561330 - Professional Employer Organizations
  • Place of Performance:

Description

Leidos Biomedical Research, Inc. (Leidos Biomed) is issuing this Request for Information (RFI) to conduct market research to identify potential organizations to support The National Cancer Institute (NCI) Genomic Data Commons (GDC).  NCI has requested services of Leidos Biomed to initiate management and execution of the NCI GDC.  Leidos Biomed is seeking organizations with experience in supporting one or more of the following areas on the NCI GDC project. Organizations are encouraged to submit a response for any of these areas of capabilities and need not have experience in all areas to submit a response: 

  • Front End Design and Development
  • Scientific Analysis Tool Integration
  • Production Data Processing

Description of Work: 

The NCI GDC  (https://gdc.cancer.gov) is a repository and cancer knowledge base established by the NCI Center for Cancer Genomics (CCG) to support the hosting, standardization, and distribution of genomic and clinical data from cancer research programs.

The mission of the GDC is to provide the cancer research community with a unified data repository that enables data sharing across cancer genomic studies in support of precision medicine. Working towards this mission, the GDC aims to provide a cancer knowledge base that enables the identification of both high and low frequency cancer drivers, assists in defining genomic determinants of response to therapy, and informs the composition of clinical trial cohorts sharing targeted genetic lesions. 

The GDC aims to expand current capabilities to support:

  • User interface design and development for front end components of the GDC
  • Adoption of innovative and scalable web-based analysis tools to operate within the GDC Analysis Tool Framework
  • High throughput production-level data processing of next generation sequencing data using GDC workflows

Expansion of these capabilities will further grow the GDC as a cancer knowledge base and result in increased efficiencies in data generation and release.

Leidos Biomed POC:

Maureen Wilson, Sr. Subcontracts Administrator  maureen.wilson2@nih.gov   

For information concerning other opportunities with the FNLCR, please refer to: https://frederick.cancer.gov/workwithus/solicitations

Contact Information

Contracting Office Address

  • 9609 Medical Center Drive
  • Rockville , MD 20850
  • USA

Primary Point of Contact

Secondary Point of Contact





History

  • Apr 15, 2022 11:55 pm EDTSpecial Notice (Original)